This inventor holds 6 USPTO granted patents and 6 published patent applications and 2 EPO patents. Top assignees: Myrexis, Inc., Epicept Corporation, Myriad Pharmaceuticals, Inc.. Active years: 1993-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Huntington Beach, CA (US) (1993)
- Salt Lake City, UT (US) (2010 - 2015)
Company Filing History:
Years Active: 1993-2015
Title: Innovations of Robert J Halter
Introduction
Robert J Halter is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative disorders. With a total of 6 patents to his name, Halter's work focuses on developing novel compounds for Alzheimer's disease.
Latest Patents
Halter's latest patents include innovative compounds aimed at treating Alzheimer's disease. One of his disclosures relates to novel indole and tetrahydroindole core compounds that are useful for addressing disorders associated with defects in vesicular transport, such as axonal transport. Another patent provides compounds that are beneficial for treating neurodegenerative disorders, including Alzheimer's disease and dementia. These compounds feature various substituents, including -L-C(=O)OH and -L-S(=O)NH, where L serves as a linker.
Career Highlights
Throughout his career, Halter has worked with several companies, including Myrexis, Inc. His research and innovations have contributed to advancements in the pharmaceutical industry, particularly in the development of treatments for complex neurological conditions.
Collaborations
Halter has collaborated with notable colleagues, including Yevgeniya Klimova and Mark B Anderson. These partnerships have enhanced his research efforts and contributed to the success of his inventions.
Conclusion
Robert J Halter's contributions to the field of pharmaceuticals, particularly in the treatment of Alzheimer's disease, highlight his innovative spirit and dedication to improving healthcare. His work continues to inspire advancements in medical research and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile